. Show Affiliations »
Abstract
Mesh: See more » Advertising/legislation & jurisprudenceCost-Benefit AnalysisDrug Industry/legislation & jurisprudenceEuropeUnited KingdomUnited StatesUnited States Food and Drug Administration
Year: 1991 PMID: 1678089
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321